LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies.

Myers, Mallory L / Gallagher, John R / Kim, Alexander J / Payne, Walker H / Maldonado-Puga, Samantha / Assimakopoulos, Haralabos / Bock, Kevin W / Torian, Udana / Moore, Ian N / Harris, Audray K

Nature communications

2023  Volume 14, Issue 1, Page(s) 1763

Abstract: Influenza virus infects millions of people annually and can cause global pandemics. Hemagglutinin (HA) is the primary component of commercial influenza vaccines (CIV), and antibody titer to HA is a primary correlate of protection. Continual antigenic ... ...

Abstract Influenza virus infects millions of people annually and can cause global pandemics. Hemagglutinin (HA) is the primary component of commercial influenza vaccines (CIV), and antibody titer to HA is a primary correlate of protection. Continual antigenic variation of HA requires that CIVs are reformulated yearly. Structural organization of HA complexes have not previously been correlated with induction of broadly reactive antibodies, yet CIV formulations vary in how HA is organized. Using electron microscopy to study four current CIVs, we find structures including: individual HAs, starfish structures with up to 12 HA molecules, and novel spiked-nanodisc structures that display over 50 HA molecules along the complex's perimeter. CIV containing these spiked nanodiscs elicit the highest levels of heterosubtypic cross-reactive antibodies in female mice. Here, we report that HA structural organization can be an important CIV parameter and can be associated with the induction of cross-reactive antibodies to conserved HA epitopes.
MeSH term(s) Female ; Animals ; Mice ; Humans ; Influenza Vaccines ; Hemagglutinins ; Antibodies, Viral ; Hemagglutinin Glycoproteins, Influenza Virus ; Orthomyxoviridae Infections ; Cross Reactions ; Influenza, Human
Chemical Substances Influenza Vaccines ; Hemagglutinins ; Antibodies, Viral ; Hemagglutinin Glycoproteins, Influenza Virus
Language English
Publishing date 2023-03-30
Publishing country England
Document type Journal Article ; Research Support, N.I.H., Extramural
ZDB-ID 2553671-0
ISSN 2041-1723 ; 2041-1723
ISSN (online) 2041-1723
ISSN 2041-1723
DOI 10.1038/s41467-023-37162-z
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top